Signos Review

Our assessment

Signos started as a continuous glucose monitor with a coaching app around it, and has bolted a clinician-prescribed GLP-1 tier onto the top of its plan ladder. The bundle is a genuinely different offer: one figure covering the medication, the sensors and the app, with no second bill. The problem is that the company's own FAQ, on the site the same day as the plans page, says it does not offer prescription medication at all.

The site doesn't agree with itself

The plans page has two tabs. One sells sensor-only plans. The other sells a tier described as clinician-prescribed GLP-1 with CGM, priced, with an included list naming a personalized treatment plan and the sensors.

The FAQ on the same site asks whether the membership includes access to prescription medication. It answers that Signos does not offer any prescription medications or medical supplements.

The footer sides with the plans page. It says medication costs are included in the program and refers to compounded medications supplied through partner pharmacies. Two surfaces out of three say the lane is real, but Signos has not settled the question on its own site.

A starting figure with no term attached

The GLP-1 tier is advertised as a starting-at rate. Its included list says the treatment plan runs three or six months. The page never says which of those the starting figure buys.

The sensor-only tiers use the same construction, with the per-month rate falling as the plan lengthens. There the term is printed on each card. On the medication tier it is not.

There is a second trap. One of the sensor-only tiers carries a list price identical to the medication tier's figure, so the same number appears twice on one page meaning two different things.

What the bundle covers

The medication, the glucose sensors, the app and shipping are all named as included, and the footer confirms medication costs sit inside the program charge. There is no second bill waiting for you.

Signos is also unusually clear about what it isn't. It says it does not employ the prescribing clinicians, names the independent network that does, and says compounded medications are not FDA-approved and have not been evaluated for safety, efficacy or quality.

It doesn't name a pharmacy, and it doesn't name a clinician. The disclosure stops at the level of the network.

Can it prescribe in your state?

The only coverage sentence on the site says the program is available in the United States and ships to all fifty states. That is a shipping claim about a sensor kit.

Prescribing is done by independent clinician networks, and Signos doesn't publish where those networks are licensed. So where the medication tier is actually available is anyone's guess.